Page last updated: 2024-09-05

tesaglitazar and Diabetic Nephropathies

tesaglitazar has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breyer, MD; Cha, DR; Fang, X; Guan, Y; Han, JY; Su, D; Wu, J; Yu, B; Zhang, X; Zhang, Y	1

Other Studies

1 other study(ies) available for tesaglitazar and Diabetic Nephropathies

Article	Year
Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes, 2007, Volume: 56, Issue:8 Topics: Adiponectin; Adipose Tissue; Alkanesulfonates; Animals; Cells, Cultured; Collagen Type I; Collagen Type IV; Diabetic Nephropathies; Gene Expression Regulation; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Phenylpropionates; PPAR alpha; PPAR gamma; Transcription, Genetic	2007

Article

Year

Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.

Diabetes, 2007, Volume: 56, Issue:8

Topics: Adiponectin; Adipose Tissue; Alkanesulfonates; Animals; Cells, Cultured; Collagen Type I; Collagen Type IV; Diabetic Nephropathies; Gene Expression Regulation; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Phenylpropionates; PPAR alpha; PPAR gamma; Transcription, Genetic

2007